Dr MacSweeney’s presentation illuminates the latest advancements in the neuroscience of Alzheimer’s, highlighting the importance of modifiable risk factors and explains the importance and impact of FDA and MHRA approval of ground-breaking disease-modifying treatments, Leqembi and Kisunla, which are available at Re:Cognition Health’s centres in the UK and USA.

The presentation will also explore the exciting pipeline of emerging treatments, focusing on the critical role of clinical trials in driving pharmaceutical innovation, which is turn is changing the future of Alzheimer’s, and other neurodegenerative diseases. Dr MacSweeney elucidates why early action is the secret; today early accurate diagnosis and access to new treatments is changing the future of those with neurogenerative diseases, especially Alzheimer’s which is now a global pandemic.

Speaker: Dr MacSweeney, Consultant Interventional Neuro-Radiologist, Co-Founder of Re:Cognition Health

Dr MacSweeney, a Consultant Interventional Neuro-Radiologist, co-founded Re:Cognition Health in 2011 to provide a specialist service for accurate diagnosis and access to the latest treatments for progressive neurodegenerative & neurodevelopmental conditions and traumatic brain injury. Today, Re:Cognition Health has 10 Centres in the UK & USA, where individuals can also benefit from the opportunity to enter global clinical trials for new diagnostic biomarkers and emerging medications.

The focus that Dr MacSweeney and her team of Brain and Mind Experts are deploying on Alzheimer’s Disease (now a global pandemic) and CTE (the most feared risk for contact sports) is having a profound difference in two of the most unacceptable medical conditions of the decade.
Dr MacSweeney was invited to speak on CTE in a TEDx Talk “CTE: The Silent Killer in Contact Sports”

Location: ABHI Stand, Hall 2 (H2.E30)